Niche Diagnostics Target a Dublin-based, privately funded molecular diagnostics company with a focus on rapid LAMP-based infectious disease tests, offering collaboration on integration, distribution, or co-development of rapid, cost-effective solutions for near-patient and lab environments.

Product Expansion Leverage HG’s growing product line (Covid-19, Meningococcus, GBS, C. difficile, Mycoplasma pneumoniae) to propose bundled or multi-analyte panels, cross-sell to labs seeking streamlined workflows and consolidated testing panels.

Regulatory Momentum Capitalize on CE Marking achievements and EU funding history to position as a strategic partner for regulatory-ready diagnostic solutions, offering you speed to market and compliance support for new infectious disease tests.

Strategic Partnerships Explore collaboration opportunities with academia and hospitals already engaged (QUB, Genoa hospital) to access pilot sites, clinical validation, and regional expansion, accelerating credibility and adoption in new geographies.

SMB Focused HiberGene’s small team size and revenue profile indicate readiness for scalable channel partnerships, distribution deals, and co-marketing programs that leverage their rapid, user-friendly LAMP-based testing to penetrate cost-sensitive markets.